TORONTO, July 3, 2025 /CNW/ - Vertex Pharmaceuticals (Nasdaq: VRTX) recently announced positive longer-term data for Pr CASGEVY ® (exagamglogene autotemcel) from global ongoing pivotal clinical trials ...

Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 1.82% on an annualized basis producing an average annual return of 13.32%. Currently, Vertex Pharmaceuticals has a ...

A tiny implant just helped paralyzed rats walk again—is human recovery next? An implantable electronic device has restored movement following spinal cord injury in an animal study.

Vertex Pharmaceuticals, a US-based drugmaker known for transformative therapies, is developing a new treatment called Zimislecel (formerly VX-880) that could revolutionize how Type 1 Diabetes (T1D ...

In another article, we covered Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and shared the list of best biotech stocks to invest in.

The 5-year-old canine's left hind leg was treated after experiencing vehicular trauma.

7 People Now Have Elon Musk's Neuralink Brain Implant The brain-computer interface lets those with cervical spinal cord injuries or ALS control a computer with their thoughts.

About Vertex Pharmaceuticals Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases.

Vertex Pharmaceuticals: 2025 TIME100 Most Influential CompaniesBoston and London biotech company Vertex Pharmaceuticals is on a roll. In the past year and a half, Vertex worked with CRISPR ...